CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 74 filers reported holding CITIUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,507,420 | -40.4% | 2,202,542 | +4.5% | 0.00% | – |
| Q2 2023 | $2,528,330 | +353.4% | 2,106,942 | +342.1% | 0.00% | – |
| Q1 2023 | $557,618 | -20.3% | 476,597 | -46.2% | 0.00% | – |
| Q4 2022 | $699,304 | +30.5% | 885,194 | +100.0% | 0.00% | – |
| Q3 2022 | $536,000 | +31.7% | 442,597 | 0.0% | 0.00% | – |
| Q2 2022 | $407,000 | -89.0% | 442,597 | -78.6% | 0.00% | – |
| Q1 2022 | $3,699,000 | +15.0% | 2,066,567 | -1.0% | 0.00% | – |
| Q4 2021 | $3,216,000 | -26.8% | 2,088,221 | -3.5% | 0.00% | – |
| Q3 2021 | $4,395,000 | -35.9% | 2,164,831 | +10.0% | 0.00% | – |
| Q2 2021 | $6,852,000 | – | 1,968,922 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Inspire Advisors, LLC | 188,796 | $291,000 | 0.08% |
| Horst & Graben Wealth Management LLC | 75,722 | $117,000 | 0.03% |
| Alpine Global Management, LLC | 83,475 | $129,000 | 0.02% |
| Miller Investment Management, LP | 50,000 | $77,000 | 0.01% |
| SABBY MANAGEMENT, LLC | 30,863 | $48,000 | 0.01% |
| WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC | 49,075 | $76,000 | 0.00% |
| Alberta Investment Management Corp | 172,185 | $265,000 | 0.00% |
| Syverson Strege & Co | 2,145 | $3,000 | 0.00% |
| HighTower Advisors, LLC | 170,623 | $263,000 | 0.00% |
| HRT FINANCIAL LP | 90,871 | $139,000 | 0.00% |